Stock Price Quote

LINCOLN PHARMACEUTICALS LTD.

NSE : LINCOLNBSE : 531633ISIN CODE : INE405C01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE208.406 (+2.96 %)
PREV CLOSE ( ) 202.40
OPEN PRICE ( ) 202.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12068
TODAY'S LOW / HIGH ( )202.00 211.85
52 WK LOW / HIGH ( )124.4 219.5
NSE208.405.95 (+2.94 %)
PREV CLOSE( ) 202.45
OPEN PRICE ( ) 202.00
BID PRICE (QTY) 208.40 (19)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 129996
TODAY'S LOW / HIGH( ) 202.00 212.00
52 WK LOW / HIGH ( )124.35 221
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-01 1995
Management Info
Kishor M Shah - Chairman Mahendra G Patel - Managing Director
Registered Office

Address Lincoln House", Behind Satyam Complex,Science City Road,Sola,
Ahmedabad,
Gujarat-380060

Phone 079-30018000

Email info@lincolnpharma.com

Website www.lincolnpharma.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, Ahmedabad

NEWS

09Dec Announcement under Regulation 30 (LOD
In compliance with Regulation 30 of the SEBI (Listing Obligations and Di..
09Dec Amalgamation
inter alia, approved the following: 1. It is decided to withdraw the Sch..
03Dec Amalgamation
Inter alia consider and approve the following: 1. To Withdrawal the In-..
22Oct Announcement under Regulation 30 (LOD
Please find enclosed a copy of press release dated October 22, 2019 titl..
22Oct Lincoln Pharmaceuticals receives paten
Lincoln Pharmaceuticals has been awarded a patent for its liquid Diclofe..

Financials

in Millions
QTR Sep 19 ANNUAL 19
Net Profit179.88466.37
Gross Profit 236.17 581.42
Operating Profit 254.88669.05
Net Sales 1105.973530.43

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE)
peergroup  4165.75 (2.76%)
M.Cap ( in Cr)19057.36
Alkem Laboratories (BSE)
peergroup  2351.55 (0.95%)
M.Cap ( in Cr)28116.31
Aarti Drugs (BSE)
peergroup  622.85 (3.43%)
M.Cap ( in Cr)1451.24
Themis Medicare (BSE)
peergroup  413.95 (5.00%)
M.Cap ( in Cr)380.05
Wockhardt (BSE)
peergroup  299.05 (6.44%)
M.Cap ( in Cr)3311.53

Shareholding Pattern

NON-INSTITUTION 67.33%
PROMOTERS 32.4%
FI/BANKS/INSURANCE 0.19%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Lincoln Pharmaceuticals Ltd.

Lincoln Pharmaceuticals Ltd. was incorporated in the year 20-01-1995. Its today's share price is 208.4. Its current market capitalisation stands at Rs 416.8 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3661.81 Cr and Total Income of Rs.3718.32 Cr. The company's management includes Bhavik P Parikh, Saurin J Parikh, Meha Patel, Pirabhai Suthar, Ishwarlal Patel, Arvind G Patel, Rajnikant G Patel, Ashish Patel, Munjal M Patel, Hashmukhbhai Patel, Mahendra G Patel, Kishor M Shah.

It is listed on the BSE with a BSE Code of 531633 , NSE with an NSE Symbol of LINCOLN and ISIN of INE405C01035. It's Registered office is at Lincoln House", Behind Satyam Complex,Science City Road,SolaAhmedabad-380060, Gujarat. Their Registrars are ACC Ltd. It's auditors are Chandulal M Shah & Co, DK Chhajer & Co, JT Shah & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X